Therapeutic strategies to target Cav‐1 for the treatment of AIDs may include: (1) Cav‐1 inhibitors: therapeutic agents that work by blocking the expression or function of Cav‐1, thereby influencing intracellular signal transduction pathways. This evidence concerns the gene CAV1 and AIDS.